Aclaris Therapeutics, Inc. (ACRS) by event type
ACRS moves most on analyst upgrades — a median of +2.14% at 30 minutes across 28 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the ACRS overview →
How ACRS reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 28 of 2,717 | 28 | +2.14% | 71% | +1.94% |
| Analyst downgrades 2,078 of 2,603 | 22 | -0.36% | 36% | +1.07% |
| Coverage initiations 2,056 of 2,283 | 24 | -0.81% | 33% | -1.20% |
| Rating reiterations 1,583 of 3,522 | 45 | 0.00% | 40% | +1.09% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how ACRS usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · ACRS overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | 276 | +0.21% | 51% |
| Xenon Pharmaceuticals Inc. - Common Shares (XENE) | 276 | +0.03% | 50% |
| Anika Therapeutics Inc. (ANIK) | 275 | +0.07% | 52% |
| Delcath Systems, Inc. (DCTH) | 275 | -0.27% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.